top of page
FAQ
Frequently asked questions
FAQs
As a physician-managed compounding facility, we comply with 503A regulations under the FD&C Act, allowing us to supply semaglutide and tirzepatide directly to your practice without needing patient-specific prescriptions. We source from licensed and exempt facilities, ensuring reliable, high-quality medications. Each batch comes with a Certificate of Analysis (COA), and we offer both non-lyophilized (90-day shelf life) and lyophilized (2-year shelf life) options. With competitive pricing, same-day FedEx shipping, and free shipping on orders over 150 mg, we support over 300 medical practices nationwide.
Semaglutide has rapidly gained popularity for its impressive results in helping patients achieve significant weight loss. This FDA-approved medication has been shown to reduce body weight by up to 15% in clinical trials, making it a game-changer in the battle against obesity. Clinical studies indicate that 99% of patients experience significant weight loss, and it’s proven safe for long-term use.
Tirzepatide is a new injectable medication that combines GLP-1 and GIP actions to promote safe and effective weight loss. It stimulates insulin secretion, lowers glucagon levels, and enhances feelings of fullness, helping reduce food intake and support significant weight loss in patients with obesity or overweight conditions.
Administered weekly via subcutaneous injection, tirzepatide has shown promising results in clinical trials, with participants experiencing substantial weight reductions. It is typically integrated into comprehensive weight loss programs and monitored for safety, with mild gastrointestinal side effects that usually diminish over time.
Patient education on proper administration and benefits ensures adherence and supports positive outcomes. With ongoing research into its broader applications, tirzepatide offers a promising option for weight management in clinical settings.
bottom of page